TY - JOUR
T1 - Does repeated surgery improve the prognosis of colorectal liver metastases?
AU - Morise, Zenichi
AU - Sugioka, Atsushi
AU - Fujita, Junko
AU - Hoshimoto, Sojun
AU - Kato, Takazumi
AU - Hasumi, Akitake
AU - Suda, Takashi
AU - Negi, Hiromichi
AU - Hattori, Yoshinobu
AU - Sato, Harunobu
AU - Maeda, Kotaro
PY - 2006/1/1
Y1 - 2006/1/1
N2 - Hepatic resection for colorectal metastases was performed for 188 patients. Overall survival rates after the first hepatectomy are 41.4% and 32.7% for 5 and 10 years, respectively. The survival rate of 116 cases with unilobar hepatic metastases (H1) is significantly higher than those of 48 cases with two to four bilobar metastases (H2) and 24 cases with more than four (H3), respectively. However, the differences between the survival rates from H1 with multiple metastases, H2, and H3 are not significant, even though the H3 group has no 10-year survivors. The 5-year survival rates after the second hepatectomy (30 patients) and the resection of the lung (26 patients) are 30.3% and 35.2%, respectively, in this series. In those patients, the 5-year survival rates from the first metastasectomy are 43.4% and 50.3%, respectively. There are 14 5-year survivors with multiple metastases and 8 of those patients underwent multiple surgeries. There are 13 patients with three or more repeat resections of the liver and/or lung. The 5-year survival rates of the patients from the first and third metastasectomy are 53.9% and 22.5%, respectively. Repeat operations for the liver and the lung contribute to the improving prognosis.
AB - Hepatic resection for colorectal metastases was performed for 188 patients. Overall survival rates after the first hepatectomy are 41.4% and 32.7% for 5 and 10 years, respectively. The survival rate of 116 cases with unilobar hepatic metastases (H1) is significantly higher than those of 48 cases with two to four bilobar metastases (H2) and 24 cases with more than four (H3), respectively. However, the differences between the survival rates from H1 with multiple metastases, H2, and H3 are not significant, even though the H3 group has no 10-year survivors. The 5-year survival rates after the second hepatectomy (30 patients) and the resection of the lung (26 patients) are 30.3% and 35.2%, respectively, in this series. In those patients, the 5-year survival rates from the first metastasectomy are 43.4% and 50.3%, respectively. There are 14 5-year survivors with multiple metastases and 8 of those patients underwent multiple surgeries. There are 13 patients with three or more repeat resections of the liver and/or lung. The 5-year survival rates of the patients from the first and third metastasectomy are 53.9% and 22.5%, respectively. Repeat operations for the liver and the lung contribute to the improving prognosis.
UR - http://www.scopus.com/inward/record.url?scp=29244446284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29244446284&partnerID=8YFLogxK
U2 - 10.1016/j.gassur.2005.09.006
DO - 10.1016/j.gassur.2005.09.006
M3 - Article
C2 - 16368485
AN - SCOPUS:29244446284
SN - 1091-255X
VL - 10
SP - 6
EP - 11
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
IS - 1
ER -